Leisure Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Leisure Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$357K	Sell	712 -3	-0.4%	-$1.44K	0.11%	118
2026 Q1	$351K	Sell	715 -2	-0.3%	-$1.08K	0.12%	113
2025 Q4	$415K	Buy	717 +5	+0.7%	+$2.83K	0.14%	108
2025 Q3	$345K	Sell	712 -10	-1%	-$4.66K	0.12%	108
2025 Q2	$293K	Hold	722	–	–	0.11%	112
2025 Q1	$359K	Hold	722	–	–	0.15%	108
2024 Q4	$376K	Buy	722 +10	+1%	+$5.5K	0.15%	113
2024 Q3	$440K	Hold	712	–	–	0.19%	108
2024 Q2	$394K	Hold	712	–	–	0.18%	109
2024 Q1	$414K	Sell	712 -98	-12%	-$55K	0.21%	104
2023 Q4	$430K	Hold	810	–	–	0.23%	102
2023 Q3	$410K	Sell	810 -4	-0.5%	-$2.13K	0.24%	100
2023 Q2	$425K	Hold	814	–	–	0.23%	103
2023 Q1	$469K	Sell	814 -50	-6%	-$28.2K	0.27%	99
2022 Q4	$476K	Sell	864 -30	-3%	-$15.9K	0.25%	107
2022 Q3	$453K	Buy	894 +31	+4%	+$17.3K	0.27%	94
2022 Q2	$469K	Hold	863	–	–	0.24%	95
2022 Q1	$510K	Hold	863	–	–	0.26%	99
2021 Q4	$576K	Sell	863 -5	-0.6%	-$3.12K	0.27%	98
2021 Q3	$496K	Buy	868 +5	+0.6%	+$2.74K	0.27%	100
2021 Q2	$435K	Sell	863 -35	-4%	-$16.5K	0.24%	106
2021 Q1	$410K	Buy	898 +35	+4%	+$16.7K	0.25%	106
2020 Q4	$402K	Hold	863	–	–	0.26%	103
2020 Q3	$381K	Hold	863	–	–	0.29%	97
2020 Q2	$313K	Hold	863	–	–	0.25%	100
2020 Q1	$245K	Buy	+863	New	+$272K	0.24%	106

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Leisure Capital Management's TMO Position: Q2 2026 in Review

Leisure Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 0.42% in Q2 2026, selling an estimated $1.44K and leaving 712 shares worth $357K. The position accounts for 0.11% of the portfolio, ranked #118.

Leisure Capital Management first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $576K in Q4 2021. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Leisure Capital Management held 712 shares of Thermo Fisher Scientific worth $357K as of Q2 2026.
Leisure Capital Management sold 3 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.44K.
Thermo Fisher Scientific made up 0.11% of Leisure Capital Management's portfolio in Q2 2026, its #118 holding.
Leisure Capital Management first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
Leisure Capital Management's Thermo Fisher Scientific position peaked at $576K in Q4 2021.
2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Leisure Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.